Low specificity of PGP9.5 expression for detection of micrometastatic neuroblastoma.

por Gilbert, J., Norris, M. D., Marshall, G. M., Haber, M.
Publicado 1997

Effect of treatment with the MER tubercle bacilli fraction on the survival of mice carrying mammary tumour isografts: injections of MER at the tumour site or at a distal location.

por Cohen, D., Yron, L., Haber, M., Robinson, E., Weiss, D. W.
Publicado 1975

An unexpected role for caspase-2 in neuroblastoma

por Dorstyn, L, Puccini, J, Nikolic, A, Shalini, S, Wilson, C H, Norris, M D, Haber, M, Kumar, S
Publicado 2014

Defining an Analytic Framework to Evaluate Quantitative MRI Markers of Traumatic Axonal Injury: Preliminary Results in a Mouse Closed Head Injury Model

por Haber, M., Hutchinson, E. B., Sadeghi, N., Cheng, W. H., Namjoshi, D., Cripton, P., Irfanoglu, M. O., Wellington, C., Diaz-Arrastia, R., Pierpaoli, C.
Publicado 2017

The retinoid anticancer signal: mechanisms of target gene regulation

por Liu, T, Bohlken, A, Kuljaca, S, Lee, M, Nguyen, T, Smith, S, Cheung, B, Norris, M D, Haber, M, Holloway, A J, Bowtell, D D L, Marshall, G M
Publicado 2005

ATP7A is a novel target of retinoic acid receptor β(2) in neuroblastoma cells

por Bohlken, A, Cheung, B B, Bell, J L, Koach, J, Smith, S, Sekyere, E, Thomas, W, Norris, M, Haber, M, Lovejoy, D B, Richardson, D R, Marshall, G M
Publicado 2009

MRP1 gene expression level regulates the death and differentiation response of neuroblastoma cells

por Peaston, A E, Gardaneh, M, Franco, A V, Hocker, J E, Murphy, K M, Farnsworth, M L, Catchpoole, D R, Haber, M, Norris, M D, Lock, R B, Marshall, G M
Publicado 2001

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee

por Ambros, P F, Ambros, I M, Brodeur, G M, Haber, M, Khan, J, Nakagawara, A, Schleiermacher, G, Speleman, F, Spitz, R, London, W B, Cohn, S L, Pearson, A D J, Maris, J M
Publicado 2009

TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells

por Marshall, G M, Bell, J L, Koach, J, Tan, O, Kim, P, Malyukova, A, Thomas, W, Sekyere, E O, Liu, T, Cunningham, A M, Tobias, V, Norris, M D, Haber, M, Kavallaris, M, Cheung, B B
Publicado 2010

Highly sensitive MRD tests for ALL based on the IKZF1 Δ3–6 microdeletion

por Venn, N C, van der Velden, V H J, de Bie, M, Waanders, E, Giles, J E, Law, T, Kuiper, R P, de Haas, V, Mullighan, C G, Haber, M, Marshall, G M, MD, Norris, van Dongen, J J M, Sutton, R
Publicado 2012

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project

por Schleiermacher, G, Mosseri, V, London, W B, Maris, J M, Brodeur, G M, Attiyeh, E, Haber, M, Khan, J, Nakagawara, A, Speleman, F, Noguera, R, Tonini, G P, Fischer, M, Ambros, I, Monclair, T, Matthay, K K, Ambros, P, Cohn, S L, Pearson, A D J
Publicado 2012